Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132888) titled 'The effectiveness of a personalized digital health intervention for improving adherence to adjuvant endocrine therapy in women with breast cancer (P-DAAC)' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xiangya School of Nursing of Central South University
Condition:
Breast cancer
Intervention:
Control group:standard medication instructions and routine telephone follow-up
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-12-30
Target Sample Size: Control group:105;Intervention group:105;
Countries of Recruitment:
China
To know mor...